• According to DelveInsight, the market for Drug Eruptions in the 7MM is projected to grow significantly during the study ...
Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.This cross-sectional cohort ...
The subgroup of patients with asthma using benralizumab with high BEC and high FeNO had the highest rates of super-responders (83.3%) and clinical remission (70.0%). Benralizumab is effective in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results